Eurofarma Laboratorios S.a.
Clinical trials sponsored by Eurofarma Laboratorios S.a., explained in plain language.
-
Weight loss drug combo trial pulled before it even started
Disease control TerminatedThis study was designed to test a new combination of two drugs (sibutramine and topiramate) for helping overweight adults with conditions like high blood pressure or diabetes lose weight. It was a large, carefully controlled trial that planned to compare the new drug against a pl…
Phase: PHASE3 • Sponsor: Eurofarma Laboratorios S.A. • Aim: Disease control
Last updated May 17, 2026 07:55 UTC
-
Diabetes combo pill study halted before it began
Disease control TerminatedThis study aimed to see if a single pill combining two diabetes drugs (SGLT2 inhibitor and thiazolidinedione) works better than taking either drug alone for people with type 2 diabetes already on metformin. The goal was to improve blood sugar control and reduce side effects like …
Phase: PHASE3 • Sponsor: Eurofarma Laboratorios S.A. • Aim: Disease control
Last updated May 17, 2026 07:39 UTC
-
Asthma inhaler showdown: new combo vs. standard care
Disease control TerminatedThis study aimed to see if a new combination inhaler (formoterol 6 mcg/fluticasone 125 mcg) works as well as an existing one (formoterol 6 mcg/budesonide 200 mcg) for people with moderate asthma. It was designed for patients aged 12 and older to help manage symptoms over 12 weeks…
Phase: PHASE3 • Sponsor: Eurofarma Laboratorios S.A. • Aim: Disease control
Last updated May 14, 2026 12:05 UTC
-
New diabetes combo study pulled before it began
Disease control TerminatedThis study aimed to see if combining two diabetes medications (an SGLT2 inhibitor and a DPP-4 inhibitor) works better than each drug alone for people with type 2 diabetes whose blood sugar is not well controlled with metformin. The trial was withdrawn before enrolling any partici…
Phase: PHASE3 • Sponsor: Eurofarma Laboratorios S.A. • Aim: Disease control
Last updated May 11, 2026 20:53 UTC
-
New pain combo for diabetic nerve pain falls flat before starting
Symptom relief TerminatedThis study was designed to test a new drug called N0750 for people with painful diabetic peripheral neuropathy (nerve pain from diabetes). It aimed to compare N0750 against two standard pain medications, Cymbalta and Lyrica, over 12 weeks. However, the trial was withdrawn before …
Phase: PHASE3 • Sponsor: Eurofarma Laboratorios S.A. • Aim: Symptom relief
Last updated May 17, 2026 07:55 UTC
-
New combo pill aims to clear stuffy noses better than antihistamine alone
Symptom relief TerminatedThis study aimed to see if a combination of levocetirizine (an allergy medicine) and pseudoephedrine (a decongestant) works better than levocetirizine alone for relieving nasal congestion in people with allergic rhinitis. The trial planned to include participants aged 12 to 65 wi…
Phase: PHASE3 • Sponsor: Eurofarma Laboratorios S.A. • Aim: Symptom relief
Last updated May 13, 2026 16:02 UTC